Legal Experts: HHS Policy Change Strips FDA Of Oversight For All LDTs
Last week’s policy statement from HHS is “a broader directive wrapped in a COVID sandwich,” one attorney says
Three lawyers tell Medtech Insight that the recent move by the US HHS to revoke the FDA’s authority to oversee laboratory developed tests extends to all LDTs, and not just those used to test for COVID-19.
